Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;124(1):188-195.
doi: 10.1002/lary.24254. Epub 2013 Jul 9.

Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy

Affiliations
Review

Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy

Roshan Sethi et al. Laryngoscope. 2014 Jan.

Abstract

Objectives/hypothesis: To review the known histopathologic findings and clinical behavior of mammary analogue secretory carcinoma (MASC).

Data sources: PubMed.

Review methods: Literature search using the terms "Mammary analogue secretory carcinoma," "Mammary analog secretory carcinoma," and "MASC" to identify all relevant publications.

Results: MASC is an unusual and rare malignant salivary gland tumor first described in 2010. It shares histologic, immunohistochemical, and genetic features with secretory carcinoma of the breast. The clinical behavior of MASC ranges from slowly growing tumors that infrequently recur after surgical resection to aggressive tumors that cause widespread metastasis and death. Many cases of MASC were discovered in archived cases previously classified as acinic cell carcinoma, mucoepidermoid carcinoma, and adenocarcinoma not otherwise specified.

Conclusion: MASC is a newly recognized variant of salivary gland malignancy. Further research is needed to better delineate its overall prevalence and to define an appropriate treatment algorithm for this new clinical entity.

Keywords: Salivary gland carcinoma; head and neck surgery; mammary analogue secretory carcinoma; parotid malignancy.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1. Magnetic resonance image (MRI) axial images
A) T1 sequence pre-Gadolinium demonstrates a well-circumscribed right parotid lesion hyperintense relative to muscle B) T1 sequence post-Gadolinium demonstrates partial enhancement C) T2 sequence demonstrates hyperintensity relative to parotid gland.
FIGURE 2
FIGURE 2. Fine needle aspirate
A-B) Papanicolaou stained ThinPrep slide showing tumor cells with crowding, enlarged nuclei with promiment nucleoli, and cytoplasmic vacuolization C) Hematoxylin and eosin stained cell block preparation showing cells with vacuolization of the eosinophilic cytoplasm and a microcystic architecture.
FIGURE 3
FIGURE 3. Gross and histologic pathology of the tumor
A) Gross appearance is that of a well-circumscribed partially cystic tumor B-C) Low-powered view demonstrates solid, microcystic and pseudopapillary architectural patterns with abundant eosinophilic, colloid-like secretions D) High-powered view reveals tumor cells with eosinophilic finely granular to vacuolated cytoplasm and round to oval nuclei with prominent nucleoli. (B-D, Hematoxylin and Eosin stains).

References

    1. Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608. - PubMed
    1. Ozguroglu M, Tascilar K, Ilvan S, Soybir G, Celik V. Secretory carcinoma of the breast. Case report and review of the literature. Oncology. 2005;68:263–268. - PubMed
    1. Pia-Foschini M, Reis-Filho JS, Eusebi V, Lakhani SR. Salivary gland-like tumours of the breast: surgical and molecular pathology. J Clin Pathol. 2003;56:497–506. - PMC - PubMed
    1. Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2:367–376. - PubMed
    1. Wai DH, Knezevich SR, Lucas T, Jansen B, Kay RJ, Sorensen PH. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene. 2000;19:906–915. - PubMed

Supplementary concepts

LinkOut - more resources